Ian Bledsoe, MD
Associate Professor
Neurology
School of Medicine

Bledsoe has a special interest in dystonia, a disorder that causes involuntary movements, cramps and abnormal postures. He particularly focuses on a form of the condition that affects musicians and other patients whose work requires repetitive movements.

Bledsoe's research interests include finding better treatments for dystonia and using neuroimaging – advanced image-producing technologies applied to the nervous system – to improve understanding of what causes the condition. He has also used neuroimaging to study cognitive problems associated with Parkinson's disease.

Bledsoe received his medical degree from the University of Pittsburgh School of Medicine. He then completed a residency in neurology as well as a fellowship in clinical neurophysiology and electromyography at Stanford Health Care. At Rush University Medical Center in Chicago, he also completed a fellowship in movement disorders and a master's degree in clinical research.

Bledsoe is a member of the American Academy of Neurology, International Parkinson and Movement Disorder Society, and Performing Arts Medicine Association.

Before attending medical school, Bledsoe earned a bachelor's degree in violin performance at Northwestern University. He continues to play and perform in his free time.

• Prefrontal Physiomarkers of Anxiety and Depression in Parkinson's Disease.
  Frontiers in neuroscience 2021 de Hemptinne C, Chen W, Racine CA, Seritan AL, Miller AM, Yaroshinsky MS, Wang SS, Gilron R, Little S, Bledsoe I, San Luciano M, Katz M, Chang EF, Dawes HE, Ostrem JL, Starr PA
• Commentary: Paraneoplastic Syndrome Associated with Kelch-Like Protein 11 Antibodies Presenting with Progressive Ataxia and Tremor.
  Movement disorders clinical practice 2021 Fasano A, Prakash P, Bledsoe IO, Balint B
• Paraneoplastic Syndrome Associated with Kelch-Like Protein 11 Antibodies Presenting with Progressive Ataxia and Tremor.
  Movement disorders clinical practice 2021 Prakash P, Bledsoe IO
• Embedded adaptive deep brain stimulation for cervical dystonia controlled by motor cortex theta oscillations.
  Experimental neurology 2021 Johnson V, Wilt R, Gilron R, Anso J, Perrone R, Beudel M, Piña-Fuentes D, Saal J, Ostrem JL, Bledsoe I, Starr P, Little S
• Long-term wireless streaming of neural recordings for circuit discovery and adaptive stimulation in individuals with Parkinson's disease.
  Nature biotechnology 2021 Gilron R, Little S, Perrone R, Wilt R, de Hemptinne C, Yaroshinsky MS, Racine CA, Wang SS, Ostrem JL, Larson PS, Wang DD, Galifianakis NB, Bledsoe IO, San Luciano M, Dawes HE, Worrell GA, Kremen V, …
• Twelve Drummers Drumming… With Dystonia.
  Tremor and other hyperkinetic movements (New York, N.Y.) 2021 Bledsoe IO, Reich SG, Frucht SJ, Goldman JG
• Thalamic deep brain stimulation for acquired dystonia in children and young adults: a phase 1 clinical trial.
  Journal of neurosurgery. Pediatrics 2020 San Luciano M, Robichaux-Viehoever A, Dodenhoff KA, Gittings ML, Viser AC, Racine CA, Bledsoe IO, Watson Pereira C, Wang SS, Starr PA, Ostrem JL
• Treatment of Dystonia: Medications, Neurotoxins, Neuromodulation, and Rehabilitation.
  Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2020 Bledsoe IO, Viser AC, San Luciano M
• Medical education in movement disorders during the COVID-19 pandemic.
  Parkinsonism & related disorders 2020 Zuzuárregui JRP, Bledsoe IO, Brown EG, Dietiker CG, Galifianakis NB
• FDA Approvals and Consensus Guidelines for Botulinum Toxins in the Treatment of Dystonia.
  Toxins 2020 Spiegel LL, Ostrem JL, Bledsoe IO
• Phenomenology of Muscle Spasms in Satoyoshi Syndrome and Treatment With Botulinum Toxin Injections.
  Movement disorders clinical practice 2020 Bledsoe IO
• Phenomenology and Management of Subthalamic Stimulation-Induced Dyskinesia in Patients With Isolated Dystonia.
  Movement disorders clinical practice 2020 Bledsoe IO, Dodenhoff KA, San Luciano M, Volz MM, Starr PA, Markun LC, Ostrem JL
• Cerebellar Deep Brain Stimulation for Acquired Hemidystonia.
  Movement disorders clinical practice 2020 Brown EG, Bledsoe IO, Luthra NS, Miocinovic S, Starr PA, Ostrem JL
• Kelch-like Protein 11 Antibodies in Seminoma-Associated Paraneoplastic Encephalitis.
  The New England journal of medicine 2019 Mandel-Brehm C, Dubey D, Kryzer TJ, O'Donovan BD, Tran B, Vazquez SE, Sample HA, Zorn KC, Khan LM, Bledsoe IO, McKeon A, Pleasure SJ, Lennon VA, DeRisi JL, Wilson MR, Pittock SJ
• White matter abnormalities in the corpus callosum with cognitive impairment in Parkinson disease.
  Neurology 2018 Bledsoe IO, Stebbins GT, Merkitch D, Goldman JG
• Movement disorder society criteria for clinically established early Parkinson's disease.
  Movement disorders : official journal of the Movement Disorder Society 2018 Berg D, Adler CH, Bloem BR, Chan P, Gasser T, Goetz CG, Halliday G, Lang AE, Lewis S, Li Y, Liepelt-Scarfone I, Litvan I, Marek K, Maetzler C, Mi T, Obeso J, Oertel W, Olanow CW, Poewe W, Rios-…
• Validation of the MDS clinical diagnostic criteria for Parkinson's disease.
  Movement disorders : official journal of the Movement Disorder Society 2018 Postuma RB, Poewe W, Litvan I, Lewis S, Lang AE, Halliday G, Goetz CG, Chan P, Slow E, Seppi K, Schaffer E, Rios-Romenets S, Mi T, Maetzler C, Li Y, Heim B, Bledsoe IO, Berg D
• Corpus callosal atrophy and associations with cognitive impairment in Parkinson disease.
  Neurology 2017 Goldman JG, Bledsoe IO, Merkitch D, Dinh V, Bernard B, Stebbins GT
• Botulinum Toxin Treatment of Cervical Dystonia.
  Seminars in neurology 2016 Bledsoe IO, Comella CL
• Oculomotor assessments of executive function in preterm children.
  The Journal of pediatrics 2012 Loe IM, Luna B, Bledsoe IO, Yeom KW, Fritz BL, Feldman HM